凍結乾燥医薬品市場：薬剤クラス別、適応症別、包装タイプ別、流通チャネル別、地域別

世界の凍結乾燥医薬品市場は、2025年には3,710億9,000万米ドルと推定され、2032年には6,831億8,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR9.1％で成長すると予測されています。

図.凍結乾燥医薬品市場シェア（%）、2025年地域別

世界の凍結乾燥医薬品市場の成長を牽引しているのは、安定性の向上、投与の容易さ、輸送コストの削減など、医薬品の凍結乾燥に関連するさまざまな利点です。凍結乾燥は、製剤から水分を除去することで微生物の繁殖を防ぎ、医薬品の保存期間を延長するのに役立ちます。また、冷蔵せずに医薬品を保管・輸送することも可能です。慢性疾患の増加や、新規ドラッグデリバリーソリューションに対する製薬会社の研究開発投資の増加に伴い、凍結乾燥医薬品の需要は予測期間中に大幅に増加すると予想されます。

市場力学：

世界の凍結乾燥医薬品市場は、高齢者人口の増加、慢性疾患の罹患率の上昇、保存期間が長く微生物汚染のリスクが低いといった凍結乾燥医薬品の利点によって牽引されています。しかし、凍結乾燥装置や手順に関連する高コストが市場の成長を抑制すると予想されています。一方、アジア太平洋とラテンアメリカの新興市場は、医療インフラの改善とヘルスケア支出の増加により、市場プレーヤーに有利な機会を提供すると考えられます。さらに、新規でより効率的な凍結乾燥技術の開発研究が進行しており、予測期間中に世界市場拡大の機会がさらに創出されるでしょう。

本調査の主な特徴

• 本レポートでは、世界の凍結乾燥医薬品市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（10億米ドル）および複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の凍結乾燥医薬品市場の主要企業をプロファイルしています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の凍結乾燥医薬品市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の凍結乾燥医薬品市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の凍結乾燥医薬品市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の凍結乾燥医薬品市場、薬剤クラス別、2020年-2032年、（10億米ドル）

• 抗感染
• 抗腫瘍薬
• 利尿剤
• プロトンポンプ阻害剤
• 麻酔薬
• 抗凝固剤
• NSAID
• その他

第6章 世界の凍結乾燥医薬品市場、包装タイプ別、2020年-2032年、（10億米ドル）

• バイアル
• 注射
• カートリッジ

第7章 世界の凍結乾燥医薬品市場、流通チャネル別、2020年-2032年、（10億米ドル）

• 病院薬局
• 小売薬局
• オンライン薬局

第8章 世界の凍結乾燥医薬品市場、適応症別、2020年-2032年、（10億米ドル）

• 腫瘍学
• 感染症
• 自己免疫疾患
• 消化器疾患
• 皮膚疾患
• 呼吸器疾患
• 眼科疾患
• ホルモン障害
• その他

第9章 世界の凍結乾燥医薬品市場、地域別、2020年-2032年、（10億米ドル）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋

Global Lyophilized Drugs Market is estimated to be valued at USD 371.09 Bn in 2025 and is expected to reach USD 683.18 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Figure. Lyophilized Drugs Market Share (%), By Region 2025

The global lyophilized drugs market growth is driven by various advantages associated with lyophilization of drugs such as improved stability, ease of administration, and reduced transportation costs. Lyophilization or freeze-drying helps extend the shelf life of drugs by removing water from the formulations, thereby preventing the growth of microorganisms. It also enables storage and transportation of drugs without refrigeration. With the growing prevalence of chronic diseases and increasing R&D investments of pharmaceutical companies in novel drug delivery solutions, the demand for lyophilized drugs is expected to rise substantially during the forecast period.

Market Dynamics:

The global lyophilized drugs market is driven by the growing geriatric population, rising incidence of chronic diseases, and advantages of lyophilized drugs such as longer shelf life and lower risk of microbial contamination. However, high costs associated with lyophilization equipment and procedures are expected to restrain the market growth. On the other hand, emerging markets of Asia Pacific and Latin America are likely to offer lucrative opportunities for market players owing to improving healthcare infrastructure and increasing healthcare spending in these regions. Additionally, ongoing research for development of novel and more efficient lyophilization technologies will further create opportunities for the expansion of the global market during the forecast period.

Key Features of the Study:

• This report provides in-depth analysis of the global lyophilized drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global lyophilized drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Jadavpur University, Merck & Co., Inc., and GlaxoSmithKline plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global lyophilized drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lyophilized drugs market

Detailed Segmentation-

• By Drug Class
  • Anti-infective
  • Antineoplastic
  • Diuretics
  • Proton Pump Inhibitor
  • Anesthetic
  • Anticoagulant
  • NSAID's
  • Others
• By Indication
  • Oncology
  • Infectious Disease
  • Autoimmune Disease
  • Gastrointestinal Disease
  • Dermatological Disorders
  • Respiratory Diseases
  • Ophthalmic Diseases
  • Hormonal Disorders
  • Others
• By Packaging Type
  • Vial
  • Injection
  • Cartridge
• By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer Inc.
  • Novartis AG
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Amgen Inc.
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca PLC
  • Bristol Myers Squibb Company
  • GlaxoSmithKline plc
  • Gilead Sciences, Inc.
  • Biogen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Celgene Corporation
  • Novo Nordisk A/S
  • Vertex Pharmaceuticals Incorporated
  • Takeda Pharmaceutical Company Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Indication
  • Market Snapshot, By Packaging Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Lyophilized Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Lyophilized Drugs Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Anti-infective
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Antineoplastic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diuretics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Proton Pump Inhibitor
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anesthetic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anticoagulant
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• NSAID's
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Lyophilized Drugs Market, By Packaging Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Vial
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cartridge
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lyophilized Drugs Market, By Distribution Channel , 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lyophilized Drugs Market, By Indication, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autoimmune Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastrointestinal Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dermatological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Respiratory Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ophthalmic Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hormonal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lyophilized Drugs Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel2019 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Company Profiles
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Amgen Inc.
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca PLC
  • Bristol Myers Squibb Company
  • GlaxoSmithKline plc
  • Gilead Sciences, Inc.
  • Biogen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Celgene Corporation
  • Novo Nordisk A/S
  • Vertex Pharmaceuticals Incorporated
  • Takeda Pharmaceutical Company Limited

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact